Pharmacogenetic and pharmacogenomic research for the prediction of response to antipsychotics in schizophrenia
β Scribed by M.J. Arranz; R.W. Kerwin
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 75 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The treatment of psychotic disorders, particularly schizophrenia, had been viewed with pessimism until a recent shift in focus from established or chronic illness to earlier phases of illness around the onset highlighted opportunities for enhanced recovery. Associated with this change i
## Abstract Molecular components of the dopaminergic system may play an important role in the pathophysiology of schizophrenia. In this study, we investigated the relationship of the Ser9Gly (S/G) polymorphism of the dopamine D3 receptor (DRD3) and the variable number of tandem repeats (VNTR) polym
## Background: Infliximab (ifx) is an effective therapy for refractory luminal and fistulizing crohn's disease (cd). predictors of response could improve selection of patients with a higher probability of favorable outcomes and could improve the safety profile. we aimed to develop a predictive mode